| HOME >> BIOLOGY >> TECHNOLOGY |
BOSTON (August 16, 2010) In one of only two studies of its kind, a study from researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts demonstrates that non-viral gene therapy can delay the onset of some forms of eye disease and preserve vision. The team developed nanoparticles to deliver therapeutic genes to the retina and found that treated mice temporarily retained more eyesight than controls. The study, published online in advance of print in Molecular Therapy, brings researchers closer to a non-viral gene therapy treatment for degenerative eye disorders.
"Our work shows that it is possible to attain therapeutic results using non-viral gene delivery methods, specifically, nanoparticles. Nanoparticles, which are small enough to penetrate cells and stable enough to protect DNA, are capable of preventing retinal cell death and preserving vision," said senior author Rajendra Kumar-Singh, PhD, associate professor of ophthalmology at Tufts University School of Medicine (TUSM) and member of the genetics; neuroscience; and cell, molecular, and developmental biology program faculties at the Sackler School of Graduate Biomedical Sciences at Tufts.
"The most common approach to gene therapy involves using a virus to deliver DNA to cells. While viruses are very efficient carriers, they can prompt immune responses that may lead to inflammation, cancer, or even death. Non-viral methods offer a safer alternative, but until now, efficiency has been a significant barrier," said Kumar-Singh.
In a model simulating the progression of human retinal degeneration, the researchers treated mice with nanoparticles carrying a gene for GDNF (Glial Cell Line-Derived Neurotrophic Factor), a protein known to protect the photoreceptor cells in the eye. Retinas treated with the GDNF-carrying nanoparticles showed significantly less photoreceptor cell death than controls. Preservation of these cel
'/>"/>
| Contact: Siobhan Gallagher 617-636-6586 Tufts University, Health Sciences Source:Eurekalert |
Related biology technology :
1. Stoppert Named as President and CEO at Breakthrough Renewable Technology Firm Segetis, Inc
2. Sigma-Aldrich Launches Breakthrough Genome-Editing Tools
3. Breakthrough in spinal injury treatment
4. Upcoming Energy Psychology Event - New Breakthrough Do It Yourself Healing
5. Upcoming Energy Psychology Event in Chapel Hill Will Provide Training in New Breakthrough Do It Yourself Healing
6. Pharma Opinions Site Reviews the Breakthrough Drugs of Pharmaceutical Companies
7. Breakthrough Technology Takes Egg Freezing from Myth to Dependable Reality
8. Singapore Medicine - Breakthrough Development of Cell Therapy Treatment for Cancer
9. Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast
10. Osteotechs Next Generation Grafting Material, MagniFuse(TM) Bone Graft, a Breakthrough in Bone Regeneration; MagniFuse(TM) Bone Graft seeks to redefine the standard of care in the U.S. bone graft substitute market estimated to be in excess of $1.2 billio
11. Michigan Company Founded upon What Could Be History's Most Important Breakthrough in AI and Robotics
 |
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |